Fig. 2From: Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonatesNumber of apnea episodes in the day of TDM as a function of a GA (r2 = 0.061, p = 0.01), b PMA (r2 = 0.071, p = 0.01) in preterm neonatesBack to article page